Postgrad Med J

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Helfenstein, U
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helfenstein, U
Topic Collections
Right arrowRelated Article
Postgraduate Medical Journal 2002;78:131-134
© 2002 The Fellowship of Postgraduate Medicine


REVIEW

Data and models determine treatment proposals—an illustration from meta-analysis

U Helfenstein

Correspondence to:
Correspondence to:
Dr Ulrich Helfenstein, Department of Biostatistics, Institute of Social and Preventive Medicine, University of Zurich, Sumatrastrasse 30, 8006 Zurich, Switzerland

A relevant problem in meta-analysis concerns the possible heterogeneity between trial results. If a test of heterogeneity is not significant the trials are often considered to be "homogeneous" and the individual trial results are replaced by an overall mean effect size and its confidence interval ("equal effects model"). If the trials are heterogeneous the individual trial effect sizes are conserved ("fixed effects model"). In a more flexible approach ("random effects model"), each trial makes use of knowledge from the other trials so individual effect sizes are "shrunken" towards an overall mean effect size. The more flexible tool may be useful for doctors involved in a trial when the outcome of their individual trial differs markedly from the overall mean effect size. Where a particular trial result is opposite in direction to the overall mean result, a conflict may arise: should a new patient be treated with the new method or not? The more flexible position and a graphical comparison of the three approaches are likely to be helpful in guiding the decision. Applying different models to the same data may lead to apparently paradoxical results: an individual trial result may be interpreted to be beneficial or harmful depending on the choice of model.


Keywords: statistical models; meta-analysis; random effect models; BUGS software

Abbreviations: EEM, equal effects model; FEM, fixed effects model; logOR, logarithm of odds ratio; REM, random effects model


Related Article

Clinical application of findings of clinical trials and systematic reviews
R G Newcombe
Postgrad. Med. J. 2002 78: 129-130. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
M Pirmohamed
Best evidence and the clinical decision making process
Postgrad. Med. J., May 1, 2002; 78(919): 316 - 316.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 The Fellowship of Postgraduate Medicine